These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24824952)

  • 1. Seroepidemiology and high negativity of IgG antibodies against human papillomavirus (HPV) Type 6, 11, 16, and 18 virus-like particles in women of childbearing age in Port Harcourt, Nigeria.
    Okonko IO; Ofoedu V; Okerentugba PO; Frank-Peterside N
    J Immunoassay Immunochem; 2015; 36(2):210-20. PubMed ID: 24824952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of IgG Antibodies against Human Papillomavirus (HPV) type 6, 11, 16, and 18 Virus-Like Particles in Women of Childbearing Age in Port Harcourt, Nigeria.
    Okonko IO; Ofoedu V
    J Immunoassay Immunochem; 2015; 36(6):622-38. PubMed ID: 25774633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
    Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
    J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
    Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Serological Epidemiological Survey of Antibodies against 4 HPV Subtypes in Uygur Women in Xinjiang.
    Husaiyin S; Han L; Mamat H; Husaiyin K; Wang L; Niyazi M
    Jpn J Infect Dis; 2016 Jul; 69(4):273-8. PubMed ID: 26255734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
    Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
    J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
    Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
    BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.
    Simen-Kapeu A; Kataja V; Yliskoski M; Syrjänen K; Dillner J; Koskela P; Paavonen J; Lehtinen M
    Scand J Infect Dis; 2008; 40(9):745-51. PubMed ID: 19086247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
    Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
    Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of human papillomavirus 6, 11, 16, and 18 in young primiparous women in Sao Paulo, Brazil.
    Rama CH; Villa LL; Pagliusi S; Andreoli MA; Costa MC; Thomann P; Longatto-Filho A; Eluf-Neto J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1405-10. PubMed ID: 21051985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.
    Lu B; Hagensee ME; Lee JH; Wu Y; Stockwell HG; Nielson CM; Abrahamsen M; Papenfuss M; Harris RB; Giuliano AR
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):511-6. PubMed ID: 20086109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.
    Kim S; Arduino JM; Roberts CC; Marsico M; Liaw KL; Skjeldestad FE
    Sex Transm Dis; 2011 Jul; 38(7):587-97. PubMed ID: 21301390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
    J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
    Garland SM; Steben M; Sings HL; James M; Lu S; Railkar R; Barr E; Haupt RM; Joura EA
    J Infect Dis; 2009 Mar; 199(6):805-14. PubMed ID: 19199546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006.
    Introcaso CE; Dunne EF; Hariri S; Panicker G; Unger ER; Markowitz LE
    Sex Transm Infect; 2014 Sep; 90(6):505-8. PubMed ID: 24748563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys.
    Vaccarella S; Franceschi S; Clifford GM; Touzé A; Hsu CC; de Sanjosé S; Pham TH; Nguyen TH; Matos E; Shin HR; Sukvirach S; Thomas JO; Boursaghin L; Gaitan J; Snijders PJ; Meijer CJ; Muñoz N; Herrero R; Coursaget P;
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2379-88. PubMed ID: 20826835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sourcing of the WHO human papillomavirus type 18 international standards for HPV antibody levels.
    Faust H; Eklund C; Sukvirach S; Ngamkham J; Dillner J
    J Clin Virol; 2016 May; 78():89-92. PubMed ID: 27002710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.